Three biotechs price hefty IPOs just be­fore the week­end, while a fourth and a SPAC seek spots on Wall Street

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

A hand­ful of biotechs are hit­ting Wall Street just be­fore the start of the week­end, with three com­pa­nies — Cari­bou Bio­sciences, Sophia Ge­net­ics and Ab­sci — all pric­ing big rais­es Wednes­day and Thurs­day. Gam­ma delta T cell-fo­cused IN8bio re­launched its IPO cam­paign months af­ter post­pon­ing it last No­vem­ber, seek­ing a slight­ly low­er raise. And an­oth­er SPAC has filed for a pub­lic de­but.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Vice President

Alexandria Real Estate Equities

San Francisco, CA, USA